Fate of intravenously administered rat lymphokine-activated killer cells labeled with different markers (Q34573594)

3 August 2017

Fate of intravenously administered rat lymphokine-activated killer cells labeled with different markers (English)

1 reference

3 August 2017

A A Maghazachi

1

1 reference

PubMed ID

2337903

3 August 2017

L Fitzgibbon

series ordinal

2

1 reference

3 August 2017

1 January 1990

1 reference

Cancer Immunology, Immunotherapy

3 August 2017

1 reference

3 August 2017

31

1 reference

3 August 2017

3

1 reference

3 August 2017

139-145

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01744727

3 August 2017

0 references

cites work

In vivo distribution and tissue localization of highly purified rat lymphokine-activated killer (LAK) cells.

1 reference

12 December 2020

Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells

1 reference

12 December 2020

Influence of T cells on the expression of lymphokine-activated killer cell activity and in vivo tissue distribution.

1 reference

12 December 2020

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

1 reference

12 December 2020

In vivo and in vitro effect of adoptive immunotherapy of experimental murine brain tumors using lymphokine-activated killer cells

1 reference

12 December 2020

Indium-111 chloride imaging in patients with suspected abscesses: concise communication

1 reference

12 December 2020

Influence of the donors' clinical status on in vitro and in vivo tumor-cytotoxic activation of interleukin-2-exposed lymphocytes and their circulation in different organs

1 reference

12 December 2020

Fate of H2-activated T lymphocytes in syngeneic hosts. I. Fate in lymphoid tissues and intestines traced with 3H-thymidine, 125I-deoxyuridine and 51chromium

1 reference

12 December 2020

Intracellular fluorescent labelling of cells for analysis of lymphocyte migration

1 reference

12 December 2020

Selective toxicity of rhodamine 123 in carcinoma cells in vitro

1 reference

12 December 2020

Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes

1 reference

12 December 2020

Improved therapeutic effects of interleukin 2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide

1 reference

12 December 2020

Direct fluorescent labeling of cells with fluorescein or rhodamine isothiocyanate. I. Technical aspects

1 reference

12 December 2020

Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2

1 reference

12 December 2020

Radiotoxicity of Intranuclear Tritium, 125 Iodine and 131 Iodine

1 reference

12 December 2020

Inhibition of the growth of mouse leukemia cells in culture by 5-iododeoxyuridine

1 reference

12 December 2020

Preferential homing of tumor-infiltrating lymphocytes in tumor-bearing mice

1 reference

12 December 2020

Estimation of the migration of thoracic duct lymphocytes to non-lymphoid tissues. A comparison of the distribution of radioactivity at intervals following i.v. transfusion of cells labelled with 3H, 14C, 75Se, 99mTc, 125I and 51Cr in the rat

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

The appearance of fluorescein-labelled lymphocytes in lymph following in vitro or in vivo labelling: the route of lymphocyte recirculation through mesenteric lymph nodes

1 reference

12 December 2020

Introduction of the 5-halogenated uracil moiety into deoxyribonucleic acid of mammalian cells in culture

1 reference

12 December 2020

The in vivo distribution of autologous human and murine lymphoid cells grown in T cell growth factor (TCGF): implications for the adoptive immunotherapy of tumors

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01744727

1 reference

PubMed ID

2337903

Dimensions Publication ID

3 August 2017

0 references

1 reference

PubMed ID

2337903